300920 Product Name: inotuzumab ozogamicine
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 15/04/2021 | Certificate | Certificate | 1 | /0/4/1/8/2/0800228140/docs/300920_7_spcmedcertificate20210415113306887.pdf | ||
| 15/04/2021 | Outgoing Correspondence | Decision grant | 1 | /0/4/1/8/2/0800228140/docs/300920_14_406393l504a.pdf | ||
| 15/01/2019 | Outgoing Correspondence | Outgoing Letter | 1 | /0/4/1/8/2/0800228140/docs/300920_11_outgoingcorrespondence20190116025757018.pdf | ||
| 08/01/2019 | Incoming Correspondence Paper | Accompanying letter incoming document | 3 | /0/4/1/8/2/0800228140/docs/300920_15_incomingcorrespondencepaper20190109115002097.pdf | ||
| 04/01/2019 | Incoming Correspondence Paper | 12 | /0/4/1/8/2/0800228140/docs/300920_13_incomingcorrespondencepaper20190111095741866.pdf | |||
| 18/12/2018 | Examination | Internal New | 1 | /0/4/1/8/2/0800228140/docs/300920_18_examination20181218132008764.pdf | ||
| 26/10/2018 | Incoming Correspondence Paper | 1 | /0/4/1/8/2/0800228140/docs/300920_8_incomingcorrespondencepaper20200511022050471.pdf | |||
| 02/08/2018 | Examination | Internal New | 3 | /0/4/1/8/2/0800228140/docs/300920_0_examination20180802133711370.pdf | ||
| 02/08/2018 | Outgoing Correspondence | Outgoing Letter | 3 | /0/4/1/8/2/0800228140/docs/300920_2_outgoingcorrespondence20180810113904288.pdf | ||
| 02/08/2018 | Examination | Internal New | 28 | /0/4/1/8/2/0800228140/docs/300920_6_examination20180802133649756.pdf | ||
| 02/08/2018 | Examination | Internal New | 133 | /0/4/1/8/2/0800228140/docs/300920_16_examination20180802133657338.pdf | ||
| 28/12/2017 | Outgoing Correspondence | Confirmation receipt request | 1 | /0/4/1/8/2/0800228140/docs/300920_10_184026l174.pdf | ||
| 22/12/2017 | Incoming Correspondence Paper | Accompanying letter incoming document | 1 | /0/4/1/8/2/0800228140/docs/300920_1_incomingcorrespondencepaper20171228012223203.pdf | ||
| 22/12/2017 | Application Form | First filed application form | 3 | /0/4/1/8/2/0800228140/docs/300920_3_applicationform20171228012223032.pdf | ||
| 22/12/2017 | SPC Documents | Annex SPC | 59 | /0/4/1/8/2/0800228140/docs/300920_4_supplprotectioncertificate20200511011445913.pdf | ||
| 22/12/2017 | SPC Documents | Annex SPC | 59 | /0/4/1/8/2/0800228140/docs/300920_5_supplprotectioncertificate20200511012103718.pdf | ||
| 22/12/2017 | SPC Documents | Annex SPC | 3 | /0/4/1/8/2/0800228140/docs/300920_9_supplprotectioncertificate20171228012223590.pdf | ||
| 22/12/2017 | SPC Documents | Annex SPC | 2 | /0/4/1/8/2/0800228140/docs/300920_12_supplprotectioncertificate20200511011724467.pdf | ||
| 22/12/2017 | SPC Documents | Annex SPC | 17 | /0/4/1/8/2/0800228140/docs/300920_17_supplprotectioncertificate20171228012223691.pdf | ||
| 22/12/2017 | SPC Documents | Summary of the characteristics of the product | 24 | /0/4/1/8/2/0800228140/docs/300920_19_supplprotectioncertificate20171228012223496.pdf | ||
| 22/12/2017 | SPC Documents | Marketing Authorization SPC | 3 | /0/4/1/8/2/0800228140/docs/300920_20_supplprotectioncertificate20171228012223393.pdf |